Sfoglia per Autore
Stimolazione in vivo mediante prostaglandine ed interferone dell'attività natural killer in topi trattati con ciclofosfamide. vol. 87, p. 595-603
1987-01-01 Pica, F; Rasi, G; Ciotti, A; Mastino, A
Influenza della concentrazione di adriamicina su modificazioni volumetriche e proliferazione di cellule leucemiche in vitro
1989-01-01 SINIBALDI VALLEBONA, P; Zenobi, R; Rasi, G; Premrov, M
COMBINATION THERAPY WITH THYMOSIN ALPHA-1 POTENTIATES THE ANTITUMOR-ACTIVITY OF INTERLEUKIN-2 WITH CYCLOPHOSPHAMIDE IN THE TREATMENT OF THE LEWIS LUNG-CARCINOMA IN MICE
1992-01-01 Mastino, A; Favalli, C; Grelli, S; Rasi, G; Pica, F; Goldstein, A; Garaci, E
Rationale for therapeutic approaches with thymic hormones, interleukin 2 and interferon in combination with chemotherapy.
1992-01-01 Favalli, C; Mastino, A; Grelli, S; Pica, F; Rasi, G; Garaci, E
Characterization of four newly established melanoma cell lines
1992-01-01 Melino, G; SINIBALDI VALLEBONA, P; Spagnoli, L; Vernole, P; Rasi, G; D'Atri, S; Tartaglia, L; Catani, Mv; Annichiarico Petruzzelli, M; Finazzi Agrò, A; Garaci, E
Combination therapy with thymosin alpha 1 potentiates the anti-tumor activity of interleukin-2 with cyclophosphamide in the treatment of the Lewis lung carcinoma in mice
1992-02-01 Mastino, A; Favalli, C; Grelli, S; Rasi, G; Pica, F; Goldstein, A; Garaci, E
Characterization of three melanoma cell lines (TVM-A12, TVM-A-197, TVM-BO): Sensitivity to lysis and effect of retinoic acid
1993-01-01 Melino, G; Sinibaldi-Vallebona, P; D'Atri, S; Annicchiarico-Petruzzelli, M; Rasi, G; Catani, Mv; Tartaglia, Rl; Vernole, P; Spagnoli, Lg; Finazzi-Agro, A; Garaci, E
ANTITUMOR EFFECT OF COMBINED TREATMENT WITH THYMOSIN ALPHA-1 AND INTERLEUKIN-2 AFTER 5-FLUOROURACIL IN LIVER METASTASES FROM COLORECTAL-CANCER IN RATS
1994-01-01 Rasi, G; Silecchia, G; SINIBALDI VALLEBONA, P; Spaziani, E; Pierimarchi, P; Sivilia, M; Tremiterra, S; Garaci, E
BIOCHEMOTHERAPY WITH THYMOSIN-ALPHA-1, INTERLEUKIN-2 AND DACARBAZINE IN PATIENTS WITH METASTATIC MELANOMA - CLINICAL AND IMMUNOLOGICAL EFFECTS
1994-01-01 Lopez, M; Carpano, S; Cavaliere, R; Dilauro, L; Ameglio, F; Vitelli, G; Frasca, A; Vici, P; Pignatti, F; Rosselli, M; Rasi, G; Garaci, E
Sequential biochemotherapy for metastatic colorectal cancer using, fluorouracil, folinic acid, thymopentin and interleukin-2: Clinical and immunological effects
1995-01-01 Lopez, M; Dilauro, L; Paoletti, G; Santini, S; Gandolfo, G; Vitelli, G; Frasca, A; Ameglio, F; Rasi, G; Garaci, E
Sequential chemoimmunotherapy for advanced non-small cell lung cancer using cisplatin, etoposide, thymosin-alpha 1 and interferon-alpha 2a
1995-01-01 Garaci, E; Lopez, M; Bonsignore, G; Dellagiulia, M; Daprile, M; Favalli, C; Rasi, G; Santini, S; Capomolla, E; Vici, P; Dilauro, L
Combination low-dose lymphoblastoid interferon and thymosin alpha(1) therapy in the treatment of chronic hepatitis B
1996-01-01 Rasi, G; Mutchnick, M; Divirgilio, D; SINIBALDI VALLEBONA, P; Pierimarchi, P; Colella, F; Favalli, C; Garaci, E
Combined treatment with thymosin-alpha1 and low-dose interferon-alpha after ifosfamide in non-small cell lung cancer: A phase-II controlled trial
1996-01-01 Salvati, F; Rasi, G; Portalone, L; Antilli, A; Garaci, E
Combination low-dose lymphoblastoid interferon and thymosin α1 therapy in the treatment of chronic hepatitis B
1996-01-01 Rasi, G; Mutchnick, M; Di Virgilio, D; SINIBALDI VALLEBONA, P; Pierimarchi, P; Colella, F; Favalli, C; Garaci, E
Combination thymosin alpha(1) and lymphoblastoid interferon treatment in chronic hepatitis C
1996-01-01 Rasi, G; Divirgilio, D; Mutchnick, Mg; Colella, F; SINIBALDI VALLEBONA, P; Pierimarchi, P; Valli, B; Garaci, E
A new tumour associated antigen of non-small cell lung cancer: Tumour Liberated Proteins (TLP) - A possible new tumor marker
1996-01-01 Garaci, E; Sinibaldi, P; Rasi, G
A new tumour associated antigen of non-small cell lung cancer: Tumour liberated proteins (TLP) - A possible new tumor marker
1996-01-01 Garaci, E; Sinibaldi, P; Rasi, G
Combination therapy with BRMs in cancer and infectious diseases
1997-01-01 Garaci, E; Pica, F; Rasi, G; Palamara, At; Favalli, C
Combination therapy with BRMs in cancer and infectious diseases
1997-06-01 Garaci, E; Pica, F; Rasi, G; Palamara, A; Favalli, C
Cytoplasmic localization of anthracycline antitumor drugs conjugated with reduced glutathione: a possible correlation with multidrug resistance mechanisms
1998-01-01 Serafino, A; SINIBALDI VALLEBONA, P; Gaudiano, G; Koch, Th; Rasi, G; Garaci, E; Ravagnan, G
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile